Canadian Cannabis LP
Tier 3 Index

The Canadian Cannabis LP Tier 3 Index represents the publicly-traded market for companies that have quarterly cannabis sales below $5 million.

The Canadian Cannabis LP Tier 3 index is equal-weighted at the time of the month-end rebalancing and includes includes members of the Canadian Cannabis LP Index with quarterly sales of cannabis below $5 million. The index members are based on information that was available on 08/27/20. To qualify, companies must have a stock price of at least $0.20 a the time of rebalancing or a most recent quarterly revenue attributable to cannabis sales in excess of $2.5 million, a rule that changed on 6/30/20 after being implemented as of 12/31/19 at $1 million. The maximum revenue was increased from $2.5 million on 6/30/20. Before 12/31/18, the group included those LPs licensed by Health Canada to cultivate but not yet permitted to sell.

Inclusion in the index is not an endorsement or recommendation of any company. The companies included are designed to represent the overall market for the medical and legal marijuana sector. To summarize, it includes both the good and the bad. This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. Data delayed 15 minutes unless otherwise indicated.

Visit and bookmark the data-driven, fact-based Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures.